Product Description
Ace Cells Lab Limited is developing ACE CSD as a treatment for chronic skin diseases. (Sourced from: https://www.ace-cells.co.uk/?page_id=44)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Unknown
Route of Administration: Topical
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Ace Cells Lab Limited
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 1: Psoriasis|Dermatitis, Atopic
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT03485560 |
ACEcsd | P1 |
Unknown status |
Dermatitis, Atopic|Psoriasis |
2018-11-01 |
2019-11-05 |
Primary Endpoints|Treatments|Trial Status |
Recent News Events
Date |
Type |
Title |
|---|